Evidence map›Paper›PMID 33337256›Full record

ArticleJournal of health services research & policy2021

Impact of the COVID-19 pandemic on persons with multiple sclerosis: Early findings from a survey on disruptions in care and self-reported outcomes.

Tommaso Manacorda, Paolo Bandiera, Federica Terzuoli, Michela Ponzio, Giampaolo Brichetto, Paola Zaratin, Daiana Bezzini, Mario A Battaglia

Open access · hybridAbstract read
In one paragraph

Article in Journal of health services research & policy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. The quality of life impact of the COVID-19 pandemic and lockdowns for people living with multiple sclerosis (MS): evidence from the Australian MS Longitudinal Study.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024
    Article
  6. Article
  7. Article
  8. Exploring COVID-19 experiences for persons with multiple sclerosis and carers: An Australian qualitative study.Health expectations : an international journal of public participation in health care and health policy · 2023
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Impact of COVID-19 lockdown on progressive multiple sclerosis patients.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Tommaso ManacordaResearch Fellow, Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, UK.ORCID 0000-0002-9163-4222
Paolo BandieraDirector, Advocacy and Legal Department, Italian Multiple Sclerosis Society, Italy.
Federica TerzuoliProject Manager, Advocacy and Legal Department, Italian Multiple Sclerosis Society, Italy.
Michela PonzioResearcher, Scientific Research Area, Italian Multiple Sclerosis Foundation, Italy.
Giampaolo BrichettoResearcher, Scientific Research Area, Italian Multiple Sclerosis Foundation, Italy.ORCID 0000-0003-2026-3572
Paola ZaratinResearch Director, Scientific Research Area, Italian Multiple Sclerosis Foundation, Italy.
Daiana BezziniResearcher, Department of Life Sciences, University of Siena, Italy.
Mario A BattagliaPresident, Italian Multiple Sclerosis Foundation and Professor, Department of Life Sciences, University of Siena, Italy.
Associazione Italiana Sclerosi Multipla · ITUniversity of Siena · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo describe the disruptions in care experienced by persons with Multiple Sclerosis in Italy due to the COVID-19 pandemic and the self-reported impact on their health and wellbeing.

methodsA cross-sectional online survey was completed by 2722 persons with Multiple Sclerosis, after Italy instituted a national lockdown in response to the pandemic.

resultsPersons with Multiple Sclerosis reported that the pandemic caused broad disruptions to usual health and social care services, which impacted on their health and wellbeing. Disruptions in care were consistently associated with negative self-reported impacts on the expected progression of the disease, on out-of-pocket expenditure and on carer's stress. Psychological consequences were associated with interruption to usual psychological support, and concerns about the safety of care delivered in person.

conclusionsThe quality of life of persons with Multiple Sclerosis depends greatly on prompt access to a broad range of health and care services. Negative psychological impacts reported by persons with Multiple Sclerosis with less severe disabilities show that accessible integrated services are crucial for maintenance of their wellbeing. Most persons with Multiple Sclerosis with more severe disability experienced negative impacts on perceived health. Their carers compensating for lack of social input resulted in care overburden. As continuity of care is crucial for persons with Multiple Sclerosis, as well as for persons with chronic conditions in general, strategies must be in place to ensure it is included in future pandemic response plans.

Indexed as

AdultCaregiver BurdenContinuity of Patient CareCOVID-19Cross-Sectional StudiesDelivery of Health CareFemaleFinancing, PersonalHealth StatusHumansItalyMaleMental HealthMiddle AgedMultiple SclerosisPandemicsCOVID-19ItalyMultiple sclerosis

Identifiers

PMID33337256
PMCPMC8182334
OpenAlexW3116438536

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.